Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease-Reference-Cited by-同舟云学术

Mouse Models of NMNAT1-Leber Congenital Amaurosis (LCA9) Recapitulate Key Features of the Human Disease

Published:2016-07 Issue:7 Volume:186 Page:1925-1938
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Greenwald Scott H.,Charette Jeremy R.,Staniszewska Magdalena,Shi Lan Ying,Brown Steve D.M.,Stone Lisa,Liu Qin,Hicks Wanda L.,Collin Gayle B.,Bowl Michael R.,Krebs Mark P.,Nishina Patsy M.,Pierce Eric A.

Funder

NIH/National Eye Institute

Foundation for Retinal Research

Gavin R. Stevens Foundation

Fight for Sight

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference80 articles.

1. Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy;Perrault;Nat Genet,2012

2. Leber congenital amaurosis: genes, proteins and disease mechanisms;den Hollander;Prog Retin Eye Res,2008

3. An overview of Leber congenital amaurosis: a model to understand human retinal development;Koenekoop;Surv Ophthalmol,2004

4. Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies;den Hollander;J Clin Invest,2010

5. Intrinsically photosensitive melanopsin retinal ganglion cell contributions to the pupillary light reflex and circadian rhythm;Markwell;Clin Exp Optom,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nmnat1 Deficiency Causes Mitoribosome Excess in Diabetic Nephropathy Mediated by Transcriptional Repressor HIC1;International Journal of Molecular Sciences;2024-06-09

2. Programmed axon death: a promising target for treating retinal and optic nerve disorders;Eye;2024-03-27

3. NAD+ metabolism and eye diseases: current status and future directions;Molecular Biology Reports;2023-08-04

4. Expression of NMNAT1 in the photoreceptors is sufficient to prevent NMNAT1-associated retinal degeneration;Molecular Therapy - Methods & Clinical Development;2023-06

5. NMNAT1 and hereditary spastic paraplegia (HSP): expanding the phenotypic spectrum of NMNAT1 variants;Neuromuscular Disorders;2023-04